Regulations/Policies - Express Pharma

CDSCO issues compliance framework for SEZ-to-DTA drug transfers

FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for Revised Schedule M

CDSCO launches online registration process for CROs

Understanding opportunities and challenges for SMEs after breather on Schedule M deadline

India’s biopharma industry needs to become a little bit more ambitious

Pharma MSMEs ask for condition-free time frame of 2-3 years to implement revised Schedule M

DPDP Rules call for stringent data protection, consent management

Revised Schedule M implementation for MSMEs extended, industry welcomes move

Towards a healthier, more equitable and innovative Indian healthcare sector

MRP of 3 anti-cancer drugs to come down due to exemption from custom duty and reduction in GST